Tiglutik (riluzole oral suspension) is a liquid formulation of riluzole approved for treating amyotrophic lateral sclerosis (ALS). The medication can slow disease progression, extending survival time or the need for a tracheostomy, which is when a breathing tube is inserted through the neck into the trachea.

Rilutek (riluzole) is an oral treatment approved to slow the progression of amyotrophic lateral sclerosis (ALS). The therapy can extend survival and/or the time to a tracheostomy — a procedure wherein a tube is inserted through the neck into the windpipe to help with breathing.

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disorder that damages nerve cells and causes disability. The condition also is known as Lou Gehrig’s disease, after the famed New York Yankees baseball player who was diagnosed with the disorder in the late 1930s.

Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, is a progressive neurodegenerative disorder that runs in families in about 10% of cases. When more than one person in the same biological family is affected by the disease, it is referred to as familial ALS.

About 90% of cases of amyotrophic lateral sclerosis (ALS), the progressive neurological disorder also known as Lou Gehrig's disease, are characterized as sporadic ALS, meaning they occur spontaneously. The term sporadic in ALS means without a clear pattern, and the individuals with these cases have no known family history of the disease.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that can be classified into different types based on factors like genetics, a patient's family history, and the disorder's early symptoms. Across all types, ALS is marked by the loss of motor neurons...

Confirming a diagnosis of amyotrophic lateral sclerosis (ALS) is typically a complex process that involves testing for signs indicative of the progressive neurodegenerative disease, and ruling out other potential disorders that could cause similar symptoms.

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder in which worsening muscle weakness leads to movement problems and other symptoms such as trouble swallowing, speaking, and breathing. Patients also can experience digestive issues, mental health problems, and changes in behavior.

The exact cause of amyotrophic lateral sclerosis (ALS) is largely unknown, but a number of factors including genetics, environmental exposures, and lifestyle habits have been linked to an increased risk of ALS.